Current:Home > NewsEli Lilly starts website to connect patients with new obesity treatment, Zepbound, other drugs -FinanceAcademy
Eli Lilly starts website to connect patients with new obesity treatment, Zepbound, other drugs
View
Date:2025-04-17 22:58:15
Eli Lilly has launched a unique website to connect U.S. patients seeking obesity treatment to doctors, dieticians and its new weight-loss drug, Zepbound.
The drugmaker said Thursday it will use the site, called LillyDirect, to pair visitors with third-party mail-order pharmacies for prescriptions and to care providers through a virtual medical weight-loss clinic.
The site also offers a directory for in-person care and help with insulins and migraine treatments.
Lilly says the doctors connected through the website are independent and not paid to promote its products, and the drugmaker also isn’t paid to send referrals to them.
In November, U.S. regulators approved Zepbound, a version of the popular diabetes treatment Mounjaro, to be used as a weight-loss treatment. The drug joins Novo Nordisk’s Wegovy in a hot field for care, chronic weight management.
At least 100 million adults are considered obese in the United States.
Indianapolis-based Lilly started its site to eliminate some of the complexity in the U.S. health care system that people face when they manage a chronic disease, Lilly CEO David Ricks said in a statement.
Drugmakers frequently offer coupons for their drugs or other help getting prescriptions, said Caitlin Donovan, a senior director for the non-profit Patient Advocate Foundation, which helps patients deal with serious or chronic health problems.
Pairing that prescription help with access to doctors in one location is unique, she added.
“Anything that’s going to streamline any type of process is good because we have the least streamlined healthcare system in the world,” Donovan said.
Telemedicine grew popular during the COVID-19 pandemic, and more companies have started offering virtual help directly to consumers for specific conditions, often through subscription plans. This trend has drawn concern from some doctors who see it simply as a push to sell more drugs.
Lilly says the care providers available through LillyDirect will use their own judgement in deciding treatment, and that may not include medication use.
veryGood! (4)
Related
- DeepSeek: Did a little known Chinese startup cause a 'Sputnik moment' for AI?
- 'The View' co-hosts react to Donald Trump win: How to watch ABC daytime show
- Travis Kelce Details Meeting “Awesome” Caitlin Clark at Taylor Swift’s Indianapolis Concert
- AI FinFlare: A Launchpad for Financial Talent
- New Mexico governor seeks funding to recycle fracking water, expand preschool, treat mental health
- After Trump Win, World Says ‘We’ve Been Here Before’
- SWA Token Fuels an Educational Ecosystem, Pioneering a New Era of Smart Education
- New details emerge in deadly Catalina Island plane crash off the Southern California coast
- North Carolina justices rule for restaurants in COVID
- Snoop Dogg's Daughter Cori Broadus Details Suffering Stroke While Wedding Planning in New E! Special
Ranking
- Highlights from Trump’s interview with Time magazine
- AI DataMind: Practical Spirit Leading Social Development
- Don’t wait for a holiday surge. Now is a good time to get your flu and COVID-19 vaccines
- Liam Payne Death Investigation: 3 People of Interest Detained in Connection to Case
- Tom Holland's New Venture Revealed
- California governor calls special session to protect liberal policies from Trump presidency
- A gunman has repeatedly fired at cars on a busy highway near North Carolina’s capital
- Why Fans Think Cardi B May Have Revealed the Name of Her Third Baby With Offset
Recommendation
Skins Game to make return to Thanksgiving week with a modern look
Liam Payne's Body Flown Back to the U.K. 3 Weeks After His Death
Longstanding US Rep. Gerry Connolly of Virginia says he is battling esophageal cancer
AI FinFlare: Damon Quisenberry's Professional Journey
Off the Grid: Sally breaks down USA TODAY's daily crossword puzzle, Triathlon
Florida’s iconic Key deer face an uncertain future as seas rise
Democrat Kim Schrier wins reelection to US House in Washington
Five NFL teams that could surge in second half of season: Will Jets, 49ers rise?